Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03370016 · ClinicalTrials.gov registry record · NA

The Impact of Low Pressure Pneumo in RARP

A NA study of Prostate Cancer, sponsored by Metro Health, Michigan.

Completed
Registry status
NA
Development phase
222
Enrollment target
1
Study location

NCT03370016: Completed NA study of Prostate Cancer, sponsored by Metro Health, Michigan.

NCT03370016 is a NA study of Prostate Cancer that has completed, run by Metro Health, Michigan. The registered enrollment target is 222 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03370016, a NA study of Prostate Cancer, has completed, sponsored by Metro Health, Michigan.

COMPLETED
Registry status
NA
Development phase
222 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate clinical significance of low pressure pneumoperitoneum during robotically assisted radical prostatectomy (RARP).

Conditions Studied

Interventions

  • PROCEDURE Amount of Pneumoperitoneum Pressure applied during RARP

Study Locations (1)

Michigan

  • Metro Health - Wyoming

Trial Details

FieldValue
Enrollment Target 222 participants
Start Date 2017-10-17
Est. Completion 2020-06-30
Phase NA

Sponsor

Metro Health, Michigan

4 total trials

What the Registry Record Tells You About NCT03370016

The ClinicalTrials.gov registry entry for NCT03370016 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower). The listed sponsor is Metro Health, Michigan, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Amount of Pneumoperitoneum Pressure applied during RARP is the first listed.

NCT03370016 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03370016 about?

NCT03370016 is a clinical study titled "The Impact of Low Pressure Pneumo in RARP". The purpose of this study is to evaluate clinical significance of low pressure pneumoperitoneum during robotically assisted radical prostatectomy (RARP).

What is the current status of trial NCT03370016?

This trial is currently completed. It is a NA study. The enrollment target is 222 participants. The study started on 2017-10-17. Estimated completion is 2020-06-30.

What conditions does trial NCT03370016 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03370016?

The interventions under investigation include: Amount of Pneumoperitoneum Pressure applied during RARP (PROCEDURE).

Who is sponsoring clinical trial NCT03370016?

This trial is sponsored by Metro Health, Michigan, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03370016 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.